Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity

S Zhou, T Zhang, B Peng, X Luo, X Liu, L Hu… - International journal of …, 2017 - Elsevier
With the knowledge that the receptors of sialic acid are overexpressed on the surface of
tumor-associated macrophages (TAMs), which play a crucial role in the tumor's progression …

Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy

J Ding, D Sui, M Liu, Y Su, Y Wang, M Liu, X Luo, X Liu… - Acta Biomaterialia, 2021 - Elsevier
Neutrophils and monocytes (N/Ms) are potential candidates for the delivery of therapeutic
agents to the tumor microenvironment (TME) because of their tumor-accumulating nature. L …

Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency

T Zhang, S Zhou, L Hu, B Peng, Y Liu, X Luo… - Drug delivery and …, 2018 - Springer
Polysialic acid (PSA) is a nonimmunogenic and biodegradable polysaccharide. In recent
years, PSA has shown its potential applications to cancer treatment. In this study, PSA …

Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages

NP Tran, P Tran, SY Yoo, W Tangchang, S Lee… - Biomaterials …, 2023 - Elsevier
Tumor-associated macrophages (TAMs) in the tumor microenvironment potentially enhance
tumor growth and invasion through various mechanisms and are thus an essential factor in …

Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation

T Zhang, S Zhou, L Hu, B Peng, Y Liu, X Luo… - International Journal of …, 2016 - Elsevier
Polysialic acid (PSA) serves as a hydrophilic polymer and affords conjugated biologically
active molecules a longer circulation time in vivo. Furthermore, PSA could potentially target …

Terminating the renewal of tumor-associated macrophages: A sialic acid-based targeted delivery strategy for cancer immunotherapy

J Ding, D Zhao, Y Hu, M Liu, X Liao, B Zhao… - International Journal of …, 2019 - Elsevier
Mononuclear phagocytes are efficient drug delivery targets for cancers owing to their
cancerous tissue-accumulating nature. As receptors of sialic acid, Siglecs (sialic acid …

The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid–octadecylamine conjugate

Z She, T Zhang, X Wang, X Li, Y Song, X Cheng… - Biomaterials, 2014 - Elsevier
Based on the knowledge that sialic acid is a critical element for tumor development and its
receptors are highly expressed on the tumor-associated macrophages (TAMs) which play …

Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid–octadecylamine conjugate

J Sun, Y Song, M Lu, X Lin, Y Liu, S Zhou, Y Su… - European journal of …, 2016 - Elsevier
Dexamethasone palmitate has the potential to inhibit the activity of tumor-associated
macrophages, which promote cancer proliferation, invasion, and metastasis; however, only …

Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity

D Sui, X Tang, J Ding, Y Wang, Y Qin, N Zhang… - International Journal of …, 2021 - Elsevier
Combined administration of drugs can improve efficacy and reduce toxicity; therefore, this
combination approach has become a routine method in cancer therapy. The main …

Combined immunochemotherapy achieving targeted co-delivery of chlorogenic acid and doxorubicin by sialic acid-modified liposomes enhances anti-cancer efficacy

S Zhu, X Li, Z Luo, M Ding, S Shi, T Zhang - Drug Delivery and …, 2024 - Springer
Malignant melanoma is a high-grade aggressive skin tumor with an increasing incidence
and mortality rates worldwide. Chemotherapeutic drugs such as doxorubicin have limited …